The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout

The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout

Objective: This study examined the initial impact of a national BNT162b2 vaccine rollout on SARS-CoV-2 infections in Qatar. Methods: All individuals who had completed ≥14 days of follow-up by 16 March 2021 after receiving the BNT162b2 vaccine were included. This study calculated incidence rates (IR)...

Full description

Bibliographic Details
Main Authors: Ahmed Zaqout, Joanne Daghfal, Israa Alaqad, Saleh A.N. Hussein, Abdullah Aldushain, Muna A. Almaslamani, Mohammed Abukhattab, Ali S. Omrani
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Coronavirus
Vaccine
BNT162b2
mRNA
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221004227

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221004227

Similar Items